Genentech (RHHBY) Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
12/16/2010 9:29:57 AM
More...
|
Genentech (RHHBY) Release: ACTEMRA Data Presented at American College of Rheumatology Annual Meeting on Rapid Response and Long-Term Efficacy in People with Rheumatoid Arthritis
11/8/2010 9:24:36 AM
More...
|
Roche (RHHBY) Release: Customizing Treatment With PEGASYS(R) May Improve Chances For Success In Hepatitis C
10/27/2006 11:11:57 AM
More...
|
Herceptin Cancer Drug Wins Final British Go-Ahead
8/23/2006 9:46:38 AM
More...
|
Roche Group (RHHBY)'s Acne Meds Raises Fat Levels; Linked Heart, Liver Woes
8/22/2006 8:12:49 AM
More...
|
GlaxoSmithKline (GSK) To Sell Roche Holding's (RHHBF.PK) Drug Xenical In U.S.
10/19/2005 5:13:15 PM
More...
|
Genentech, Inc. (DNA) , Biogen Idec, Inc. (Massachusetts) (BIIB) , Roche (RHHBY) Release: Phase III Study Shows Rituxan(R) Significantly Improves Symptoms In Patients With Rheumatoid Arthritis Who Inadequately Responded To Anti-TNF Therapies
10/19/2005 5:13:13 PM
More...
|
Fujisawa Healthcare, Inc. And Roche (RHHBY) Announce Co-promotion Of MYCAMINE(TM)
10/19/2005 5:13:10 PM
More...
|
Roche (RHHBY) Release: FDA Approves Pegasys And Copegus As Only Hepatitis C Treatment For HIV Patients
10/19/2005 5:12:51 PM
More...
|
Patients Urged To Follow Painkiller Labels
10/19/2005 5:12:31 PM
More...
|
|